İ. DOĞAN Et Al. , "Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience," CLINICAL CANCER INVESTIGATION JOURNAL , no.3, pp.25-29, 2022
DOĞAN, İ. Et Al. 2022. Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience. CLINICAL CANCER INVESTIGATION JOURNAL , no.3 , 25-29.
DOĞAN, İ., Khanmammadov, N., Ahmed, M. A., Yildiz, A., Saip, P., Aydiner, A., ... VATANSEVER, S.(2022). Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience. CLINICAL CANCER INVESTIGATION JOURNAL , no.3, 25-29.
DOĞAN, İzzet Et Al. "Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience," CLINICAL CANCER INVESTIGATION JOURNAL , no.3, 25-29, 2022
DOĞAN, İzzet Et Al. "Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience." CLINICAL CANCER INVESTIGATION JOURNAL , no.3, pp.25-29, 2022
DOĞAN, İ. Et Al. (2022) . "Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience." CLINICAL CANCER INVESTIGATION JOURNAL , no.3, pp.25-29.
@article{article, author={İzzet DOĞAN Et Al. }, title={Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience}, journal={CLINICAL CANCER INVESTIGATION JOURNAL}, year=2022, pages={25-29} }